Progress of Pharmacological Approaches in Parkinson's Disease

Kirsten E. Zeuner, Eva Schäffer, Franziska Hopfner, Norbert Brüggemann, Daniela Berg*

*Corresponding author for this work
4 Citations (Scopus)


The progressive neurodegenerative process in Parkinson's disease (PD) is not restricted to dopaminergic midbrain neurons but involves the entire nervous system. In this review, we outline established treatment options at different disease stages and address new therapeutic approaches. These include, based on recent advances in the understanding of the pathophysiology of PD, genetic and disease-modifying approaches to reduce abnormal accumulation and aggregation of alpha-synuclein (aSYN), mitochondrial dysfunction, and dysfunction of lysosomal proteins. Moreover, we highlight clinical trials to reduce neuroinflammation and increase neurorestoration.

Original languageEnglish
JournalClinical Pharmacology and Therapeutics
Issue number5
Pages (from-to)1106-1120
Number of pages15
Publication statusPublished - 01.05.2019

Research Areas and Centers

  • Research Area: Medical Genetics


Dive into the research topics of 'Progress of Pharmacological Approaches in Parkinson's Disease'. Together they form a unique fingerprint.

Cite this